The two major incretin hormones are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both hormones are released after meals and contribute to maintaining normal blood glucose levels. Although they share certain functions, their production locations and physiological effects differ.
GLP-1 is primarily produced by enteroendocrine L cells located in the intestine, particularly in the lower small intestine and colon. GIP is released mainly by K cells found in the upper small intestine. These hormones communicate with the pancreas and other organs to coordinate metabolic responses following food consumption.
Their major physiological functions include:
Insulin secretion: GLP-1 and GIP stimulate pancreatic beta cells to release insulin when blood glucose levels increase.
Glucagon regulation: GLP-1 helps suppress glucagon secretion when glucose levels are elevated, reducing unnecessary glucose production by the liver.
Appetite regulation: GLP-1 influences appetite-related signals and contributes to feelings of fullness after eating.
Gastric emptying: GLP-1 slows the movement of food from the stomach into the small intestine, influencing the rate at which glucose enters the bloodstream.
Glucose homeostasis: Both hormones contribute to maintaining blood glucose levels within a regulated range.
Incretin hormones influence several metabolic processes beyond insulin secretion. After food consumption, GLP-1 and GIP help the body coordinate glucose utilization, insulin production, and energy balance. Their effects depend partly on nutrient availability and blood glucose concentrations.
The incretin effect is particularly important because it allows the digestive system to communicate with the pancreas before and during the absorption of nutrients. When glucose enters the intestine, incretin hormones are released into circulation and activate specific receptors in pancreatic cells. This supports an appropriate insulin response and helps regulate post-meal blood glucose levels.
Incretin hormones also participate in broader metabolic activities. GLP-1 affects appetite regulation through interactions with the nervous system and contributes to reduced food intake. Its influence on gastric emptying can also affect the timing of nutrient absorption. GIP participates in nutrient metabolism and has effects on pancreatic insulin secretion and adipose tissue function.
Important aspects of their metabolic influence include:
Post-meal glucose control: Incretins strengthen insulin responses following food intake.
Pancreatic activity: They support communication between intestinal cells and pancreatic hormone-producing cells.
Energy balance: GLP-1 contributes to appetite regulation and food intake.
Fat metabolism: GIP participates in metabolic processes involving adipose tissue.
Hormonal coordination: These hormones help coordinate digestive activity with the body's glucose and energy requirements.
The activity of incretin hormones is also relevant to understanding metabolic disorders, particularly type 2 diabetes. In people with type 2 diabetes, the incretin effect may be reduced, affecting the body's ability to produce an appropriate insulin response after meals. Their physiological functions provide important information about the relationship between intestinal hormone release, pancreatic activity, glucose regulation, and overall metabolic health.